Throughout the last three months, 7 analysts have evaluated Vir Biotechnology VIR, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of their recent ...

Beam Therapeutics BEAM has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives ...

Burning Rock Biotech Limited (NASDAQ: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) ...

For a while, special purpose acquisition companies were biotech’s hot ticket to the public markets. While interest in this path has died down in recent years, BridgeBio’s former cancer unit ...

Known to his followers as the Caspian Chef, Omid Roustaei prepares to celebrate the Iranian new year with "Bitter + Sweet" recipes.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

A new AI model has been developed that can quickly tell how much weeds have grown – and it could help ensure global food ...

Josh Brown, CEO of Ritholtz Wealth Management, said during a program on CNBC last month that he’s paying attention to Gilead Sciences Inc (NASDAQ:GILD).

As the famed British naturalist David Attenborough noted, “In our hands now lies not only our own future but that of all other living creatures with whom we share the Earth.” 4 In the 2000s and early ...

Take some money off the table—you’ll be able to deploy that capital at much ... bought or sold this stock in like 15 years but uh this is a longstanding sort of uh biotech pharmaceutical name used to ...

New companion diagnostics (CDx) collaboration announced with Bayer in China in May 2024.

Social media represent a new way for drug companies to interact with consumers. But transitioning medical communication and marketing campaigns to the internet poses several thorny legal and ...